Cisplatin
NDC 65219-359
Product Information
Cisplatin is a UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE-approved product labeled by Fresenius Kabi Usa, Llc. Cisplatin is used to treat various types of cancer. It is supplied as a product. This product entry covers the primary NDC 65219-359 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 65219-359?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CISPLATIN (UNII: Q20Q21Q62J)
- CISPLATIN (UNII: Q20Q21Q62J) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 309311 - CISplatin 1 MG/ML Injectable Solution
- RxCUI: 309311 - cisplatin 1 MG/ML Injectable Solution
- RxCUI: 309311 - cisplatin 100 MG per 100 ML Injectable Solution
- RxCUI: 309311 - cisplatin 50 MG per 50 ML Injectable Solution
* Please review the full disclaimer at the bottom of this page.